Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. IGC Pharma Inc. (IGC) Message Board

420 with CNW — Study Finds Workplace Accident Ra

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 436
(Total Views: 194)
Posted On: 08/15/2023 9:44:39 AM
Avatar
Posted By: NetworkNewsWire
420 with CNW — Study Finds Workplace Accident Rates No Different Between Off-Duty Marijuana Users and Non-Users

Employees who engage in off-duty marijuana consumption do not display a higher likelihood of encountering workplace injuries when compared to abstainers, according to recent research that challenges the sweeping zero-tolerance policies commonly adopted by employers. On the other hand, individuals who use marijuana during work hours exhibit a nearly twofold increase in the probability of being involved in a workplace incident, in contrast to both nonusers and those who consume marijuana during their personal time.

This discovery stems from a collaborative effort by researchers hailing from the Toronto Rehabilitation Institute, the University at Buffalo and the University of Toronto. The findings were recently published in the “Canadian Journal of Public Health.”

In two years, the study tracked 2,746 Canadian workers who occupied positions spanning both safety- and nonsafety-sensitive roles. The exhaustive analysis paid specific attention to the 11.3% subset of the sample who sustained workplace injuries during the specified timeframe.

Among the diverse pool of respondents, the investigation highlighted that 10.2% of those affected by workplace injuries were classified as nonusers, with 11.14% identified as off-duty consumers. Meanwhile, a notable 20.13% reported marijuana consumption either within two hours before or during their working hours.

According to study findings, individuals who admitted to using marijuana within the confines of their workplace exhibited a 1.97 times greater risk of encountering workplace injuries in comparison to those who refrained from such consumption. Conversely, no significant association was observed between nonworkplace usage and the occurrence of workplace injuries.

Consequently, the researchers deduced that the critical factor influencing workplace injuries is the proximity of marijuana use to work hours rather than consumption outside of professional settings.

Stratifying the data for safety-sensitive workers revealed that injury rates stood at 20.14% for nonusers, 23.3% for off-duty consumers, and 31.35% for on-the-job indulgers. For nonsafety-sensitive roles, the figures were notably lower, with nonusers experiencing injury at a rate of 4.27%, off-duty users at 4.19%, and those consuming marijuana during work at a higher 12.3%.

The researchers affirmed that their study provides a more lucid perspective on the connection between marijuana use and workplace injuries, an area that previous conflicting studies have clouded. They explained that prior research had neglected the temporal aspect of consumption concerning workplace injuries, which their study effectively accounted for.

Ultimately, the researchers concluded that solely workplace-related marijuana use poses a genuine risk of future workplace injuries, regardless of whether the job role falls within the safety-sensitive category.

Some of the concerns about marijuana use will likely disappear as more enterprises bring to market cannabis-based formulations along the lines of what IGC Pharma Inc. (NYSE American: IGC) is developing for chronic pain management. These medications will move many medical marijuana users away from taking unprocessed cannabis, which is a source of concern for employers and some authorities.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer



(0)
(0)




IGC Pharma Inc. (IGC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us